Gibraltar to Announce Third Quarter 2025 Financial Results on October 30
Get Alerts ROCK Hot Sheet
Join SI Premium – FREE
BUFFALO, N.Y.--(BUSINESS WIRE)-- Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential, agtech and infrastructure markets, announced today that it expects to release its third quarter 2025 financial results at approximately 7:30 a.m. ET on Thursday, October 30, 2025. It also expects to discuss the results on a conference call that will be webcast live that same day starting at 9:00 a.m. ET. Hosting the call will be Chief Executive Officer Bill Bosway and Chief Financial Officer Joe Lovechio.
Those who wish to listen to the conference call should visit the Investors section of the Company’s website at www.gibraltar1.com. The call also may be accessed by dialing (877) 407-3088 or (201) 389-0927. For interested individuals unable to join the live conference call, a webcast replay will be available on the Company’s website for one year.
About Gibraltar
Gibraltar is a leading manufacturer and provider of products and services for the residential, agtech and infrastructure markets. Gibraltar’s mission, to make life better for people and the planet, is fueled by advancing the disciplines of engineering, science, and technology. Gibraltar is innovating to reshape critical markets in comfortable living and productive growing throughout North America. For more please visit www.gibraltar1.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251017307142/en/
Joe Lovechio
Chief Financial Officer
(716) 826-6500, ext. 6309
[email protected]
Alliance Advisors IR
Carolyn Capaccio/Jody Burfening
(212) 838-3777
[email protected]
Source: Gibraltar Industries, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Lowered to $92 at Mizuho
- Roland Marks Ten Years Since The Future. Redefined. with Then. Now. Next. Anniversary Campaign
- eGenesis Announces Clinical Update in Ongoing Expanded Access Study of EGEN-2784 in Patients with Kidney Failure
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share